Home › Compare › EROSF vs MRK

EROSF vs MRK: Dividend Comparison 2026

EROSF yields 461.15% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EROSF wins by $33038.48M in total portfolio value
10 years
EROSF
EROSF
● Live price
461.15%
Share price
$0.43
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$33038.53M
Annual income
$23,159,309,671.43
Full EROSF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — EROSF vs MRK

📍 EROSF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEROSFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EROSF + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
EROSF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EROSF
Annual income on $10K today (after 15% tax)
$39,197.60/yr
After 10yr DRIP, annual income (after tax)
$19,685,413,220.72/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, EROSF beats the other by $19,685,404,892.31/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EROSF + MRK for your $10,000?

EROSF: 50%MRK: 50%
100% MRK50/50100% EROSF
Portfolio after 10yr
$16519.30M
Annual income
$11,579,659,734.79/yr
Blended yield
70.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

EROSF
No analyst data
Altman Z
-1.8
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EROSF buys
0
MRK buys
0
No recent congressional trades found for EROSF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEROSFMRK
Forward yield461.15% ✓2.76%
Annual dividend / share$2.00$3.32 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7% ✓
Portfolio after 10y$33038.53M ✓$56.8K
Annual income after 10y$23,159,309,671.43 ✓$9,798.13
Total dividends collected$32162.75M ✓$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EROSF vs MRK ($10,000, DRIP)

YearEROSF PortfolioEROSF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$56,815$46,114.83$11,206$366.19+$45.6K → EROSF
2$305,652$244,860.36$12,650$502.35+$293.0K → EROSF
3$1,558,168$1,231,120.53$14,407$694.19+$1.54M → EROSF
4$7,532,721$5,865,481.01$16,585$967.82+$7.52M → EROSF
5$34,560,712$26,500,700.64$19,342$1,363.89+$34.54M → EROSF
6$150,612,935$113,632,973.21$22,913$1,947.19+$150.59M → EROSF
7$623,963,119$462,807,278.35$27,662$2,823.89+$623.94M → EROSF
8$2,459,537,570$1,791,897,032.27$34,159$4,173.35+$2459.50M → EROSF
9$9,232,919,213$6,601,214,012.79$43,337$6,308.80+$9232.88M → EROSF
10$33,038,533,229$23,159,309,671.43$56,776$9,798.13+$33038.48M → EROSF

EROSF vs MRK: Complete Analysis 2026

EROSF — Stock

Eros Resources Corp. engages in the identification, acquisition, exploration, and development of mineral, and oil and gas resource properties in North America. The company explores for gold, silver, and uranium deposits. Its principal property is the Bell Mountain project, which consists of unpatented mining claims located to the southeast of Reno, Nevada. Eros Resources Corp. is based in Vancouver, Canada.

Full EROSF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this EROSF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EROSF vs SCHDEROSF vs JEPIEROSF vs OEROSF vs KOEROSF vs MAINEROSF vs JNJEROSF vs ABBVEROSF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.